{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:02:14Z","timestamp":1774742534295,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":8439,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1093\/oxfordjournals.annonc.a010502","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:37:34Z","timestamp":1334785054000},"page":"1077-1079","source":"Crossref","is-referenced-by-count":4,"title":["A phase I study of bi-weekly paclitaxel\/cisplatin as initial therapy for advanced ovarian cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"K.","family":"Swenerton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hoskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Batist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Onetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1525-1438.1992.02060301.x","article-title":"Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer","volume":"2","author":"Palmer","year":"1992","journal-title":"Int J Gynecol Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-111-4-273","article-title":"Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms","volume":"111","author":"McGuire","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0015","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1992.10.11.1748","article-title":"Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma","volume":"10","author":"Einzig","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0020","first-page":"156","article-title":"Phase II trial of taxol as second-line therapy for ovarian carcinoma: A Gynecologic Oncology Group study","volume":"9","author":"Thigpen","year":"1990","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0025","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1994.12.9.1748","article-title":"Phase II trial of paclitaxel in patients with progressive for ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group Study","volume":"12","author":"Thigpen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0030","series-title":"Second National Cancer Institute Workshop on Taxol and Taxus, Alexandra VA","article-title":"Toxicity of taxol: A European-Canadian trial of high- vs. low-dose and short vs. long infusion in ovarian cancer coordinated by the NCI Canada Clinical Trials Group","author":"Eisenhauer","year":"1992"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0035","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/jnci\/83.24.1778","article-title":"Taxol: Twenty years later, the story unfolds","volume":"83","author":"Rowinsky","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0040","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","article-title":"European-Canadian trial of paclitaxel in relapsed ovarian cancer: High- versus low-dose and long versus short infusion","volume":"12","author":"Eisenhauer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1200\/JCO.1996.14.4.1185","article-title":"A phase I\/II trial of bi-weekly paclitaxel (taxol) and cisplatin in the treatment of metastatic breast cancer","volume":"14","author":"Gelmon","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010502_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419608719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419608719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/7\/10\/1077\/340576\/7-10-1077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:06:22Z","timestamp":1582247182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419608719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S0923753419608719"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a010502","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}